2nd Annual Computational Drug Development (CDD) for Biologics Summit
In-Person Event
Dec 05 - 07, 2017
Boston, Massachusetts, USA
OVERVIEW
2nd Annual Computational Drug Development (CDD) for Biologics Summit is organized by Hanson Wade and will be held during Dec 05 - 07, 2017 at Revere Hotel Boston Common, Boston, Massachusetts, United States of America.
The 2nd Annual Computational Drug Development for Biologics Summit will once again unite computational leaders from pioneering pharmaceutical organizations, academic and software development labs. Across 3 days of jam-packed content, explore the utility and application of computational tools to the development of biologic drugs.
Biologic-based therapeutics have continued to become more complex both by modality and delivery. Much like the small molecule arena, computational tools are being sought to streamline drug design, development and manufacture.
The 2nd Annual Computational Drug Development (CDD) for Biologics Summit is dedicated to exploring the application of in-silico tools within the development paradigm for biologics.
Designed with input from thought leaders at organizations such as Genentech, Bristol-Myers Squibb, AbbVie, EMD Serono and Novartis, identify how to streamline your early drug discovery pipeline, enhance developability and improve the success rate of lead biologic candidates.
Please note: We also offer a start-up rate for small biotech organisations, as well as academic discounts. For more information and to check eligibility criteria, please visit the website.
Price:
Register By 6 October: Conference and Workshop: USD 2998,
Register By 6 October: Conference Only: USD 2499,
Standard Rate: Conference and Workshop: USD 3198,
Standard Rate: Conference Only: USD 2699,
Workshop Only: USD 699
Speakers: Stanley Krystek (Bristol Myers-Squibb), Chris Roberts (University of Delaware), Vanita Sood (EMD Serono), Sarah Sirin (AbbVie), Bernhardt L Trout (MIT)
Time: 9:00 am to 6:00 pm
Additional details will be posted as soon as they are available.
The 2nd Annual Computational Drug Development for Biologics Summit will once again unite computational leaders from pioneering pharmaceutical organizations, academic and software development labs. Across 3 days of jam-packed content, explore the utility and application of computational tools to the development of biologic drugs.
Biologic-based therapeutics have continued to become more complex both by modality and delivery. Much like the small molecule arena, computational tools are being sought to streamline drug design, development and manufacture.
The 2nd Annual Computational Drug Development (CDD) for Biologics Summit is dedicated to exploring the application of in-silico tools within the development paradigm for biologics.
Designed with input from thought leaders at organizations such as Genentech, Bristol-Myers Squibb, AbbVie, EMD Serono and Novartis, identify how to streamline your early drug discovery pipeline, enhance developability and improve the success rate of lead biologic candidates.
Please note: We also offer a start-up rate for small biotech organisations, as well as academic discounts. For more information and to check eligibility criteria, please visit the website.
Price:
Register By 6 October: Conference and Workshop: USD 2998,
Register By 6 October: Conference Only: USD 2499,
Standard Rate: Conference and Workshop: USD 3198,
Standard Rate: Conference Only: USD 2699,
Workshop Only: USD 699
Speakers: Stanley Krystek (Bristol Myers-Squibb), Chris Roberts (University of Delaware), Vanita Sood (EMD Serono), Sarah Sirin (AbbVie), Bernhardt L Trout (MIT)
Time: 9:00 am to 6:00 pm
Additional details will be posted as soon as they are available.
KEY DATES
05 Dec, 2017
Event Start Date
07 Dec, 2017
Event End Date
SPECIALITIES
Pharmacy and MedicineSUGGESTED HOTELS
CONFERENCE VENUE
Revere Hotel Boston CommonRELATED CONFERENCES & LIVE WEBINARS
Quick Links